Hysterectomy Device Market Size & Share, by End user (Hospitals, Ambulatory Surgical Centers, Gynecology Clinics); Product Type; Surgical Approach; Distribution Channel - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2034

Hysterectomy Device Market - Regional Analysis

North America Market Insights

North America is set to dominate the global hysterectomy device market with the largest share of 38.6% by the end of 2034. The leadership of the region is attributed to the ample private sector investments and regulatory advantages. Evidencing this, the U.S. Department of Health and Human Services (HHS) in 2024 proclaims that major medtech firms are expanding U.S.  manufacturing under the CHIPS Act Incentives. Meanwhile, the U.S. FDA fast-tracks the approvals for AI-integrated surgical systems, thereby encouraging more players to establish their footprint in the region. Furthermore, the robotic-assisted hysterectomies represent over 50.6% of procedures in the U.S., hence fostering a favorable business environment.

The U.S. is maintaining its dominance over the regional hysterectomy device market on account of heightened demand for minimally invasive surgeries. This can be testified by the report from the Centers for Disease Control and Prevention (CDC), which states that minimally invasive surgeries accounted for an estimated 75.5% of procedures in 2024.  Besides the provinces from federal bodies have also been remarkable, with USD 5.3 billion allocated in 2023, whereas the Medicare reimbursements display 15.7% growth over the last five years. Additionally, the rising aging demographics, i.e., 70.3% aged 50, bolster the country’s economic contribution in this sector.

Canada in the hysterectomy device market is escalating at a notable pace, facilitated by the lucrative provincial investments. For instance, the administrative body of Ontario increased its funding by a significant 18.9% from the tenure 2021 to 2024, as stated by its Ministry of Health. The Canadian Institute for Health Information (CIHI) notes that federal spending reached USD 3.8 billion in 2023 owing to the rising public healthcare demands. On the other hand, there has been a strong adoption of minimally invasive surgeries in the country, wherein 60.6% of hysterectomies are currently laparoscopic, according to Health Canada.

APAC Market Insights

Asia Pacific in the hysterectomy device market is likely to exhibit the fastest growth from 2025 to 2034.  This accelerated growth is extensively supported by rising gynecological disorders, increasing healthcare expenditure, and government initiatives promoting women’s health. This landscape is readily dominated by Japan and China, which collectively account for 60.8% the region’s revenue.  Besides, Japan also leads in terms of robotic surgery adoption, wherein 40.7% of the procedures are robotic-assisted, as stated in the Ministry of Health, Labour and Welfare (MHLW) 2024 report. The region further fosters a favorable environment for pioneers seeking global expansion.

China is unfolding remarkable growth opportunities in the hysterectomy device market, facilitated by a massive government healthcare investment and a growing patient pool. This can be evidenced by the National Medical Products Administration’s (NMPA) report, which observed a 15.4% annual growth in the hysterectomy device spending, surpassing USD 4.8 billion in 2024, with more than 1.8 million performed on a yearly basis. It also stated that the country is readily growing in domestic manufacturing capabilities, wherein 50.6% of hysterectomy devices currently utilized are produced locally, hence making it suitable for standard market growth.

India is the targeted landscape for most of the pioneers involved in the hysterectomy device market.  The healthcare expansions and government schemes expedite a favorable business atmosphere in the country. The Ministry of Health reports that under the Ayushman Bharat scheme, over 2.8 million patients received treatment in 2023, whereas the government spending increased by 18.7% over the last decade.  On the other hand, PMJAY coverage helped 500.8 million eligible women for subsidized hysterectomies, thus reinforcing the country’s capability in this sector. Also, the National Health Authority in 2024 observed a telemedicine push with 20.7% of pre-surgical consultations being carried out remotely.

Country-wise Government Provinces

Sources: Australian Dept of Health, MFDS, MDA

Europe Market Insights

Europe is expected to grow at a steady pace in the hysterectomy device market during the discussed timeframe. The rising gynecological disorders, aging populations, and increasing adoption of minimally invasive surgeries are fueling the region’s success in this sector. There has been an exceptional contribution from the region’s Medical Device Regulation (MDR 2017/745) that has remarkably accelerated innovation with an allocation of €2.9 billion for medtech R&D through the European Health Data Space. This landscape is dominated by the prominent countries Germany, France, and the U.K., which jointly grab 60.7% of the regional market.

Germany is anticipated to display robust growth in Europe’s hysterectomy device market, owing to its advanced healthcare infrastructure, high adoption of advanced technologies, and suitable reimbursement policies. In this regard, the country granted a total of €4.8 billion to hysterectomy-related care in 2024, wherein robotic-assisted procedures are currently responsible for 60.7% of all hysterectomies, marking the highest in the overall region. Further, this is supported by the Digital Healthcare Act in 2023, which expanded insurance coverage for robotic surgeries and €300.8 million in private investments for robotic surgical centers, hence fostering a greater business environment.

France is maintaining consistent progress in the regional hysterectomy device market due to the existence of suitable policy reforms and increasing preference for minimally invasive surgeries. As stated in the National Authority for Health (HAS) report, the country allocated a capital of €1.9 billion to hysterectomy devices in 2023, wherein 70.6% of procedures are currently performed utilizing MIS techniques, marking up from 55.6% in 2020. Also, the country hosts a Hospital Reform Act implemented in 2023 enables incentives for day-case hysterectomies that appreciably reduce hospitalization costs by 15.6%.

Government Investments, Policies & Funding

Sources: NHS, AIFA, AEMPS